Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;203(1):21.e1-6.
doi: 10.1016/j.ajog.2010.01.010. Epub 2010 Mar 12.

Abnormal anal cytology in HIV-infected women

Richa Tandon  1 , Amy S Baranoski, Faye Huang, Antonio de las Morenas, Olivera Vragovic, Meg Sullivan, Elizabeth A Stier
Affiliations

Abnormal anal cytology in HIV-infected women

Richa Tandon et al. Am J Obstet Gynecol. 2010 Jul.

Abstract

Objective: The purpose of this study was to assess the prevalence of and risk factors for abnormal anal cytology and human papillomavirus (HPV) infections in women who are human immunodeficiency virus (HIV) positive.

Study design: We conducted an observational single center study of 100 HIV-infected women with cervical and anal specimens that were obtained for cytologic and high-risk HPV testing with Hybrid Capture 2.

Results: Seventeen women had abnormal anal cytology; 16 women had anal HPV; 21 women had abnormal cervical cytology, and 24 women had cervical HPV. Abnormal anal cytology was associated with cervical HPV infection, abnormal cervical cytology, and anal HPV infection in univariate analysis. In multivariate analysis, abnormal anal cytology was associated with a CD4 count <200 cells/mm(3), a history of sexually transmitted disease, and concurrent cervical cytologic abnormality.

Conclusion: HIV-infected women are at high risk for abnormal cytology and HPV infections of both the anus and cervix. Risk factors for abnormal anal cytology include abnormal cervical cytology, cervical and anal HPV infections, and low CD4 count.

PubMed Disclaimer

References

    1. Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: Has highly active retroviral therapy reduced the incidence or improved the outcome? Journal of Acquired Immune Deficiency Syndromes. 2004;37(5):1563–5. - PubMed
    1. Diamond C, Taylor TH, Aboumrad T, Bringman D, Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sexually Transmitted Diseases. 2005;32(5):314–20. - PubMed
    1. D’Souza G, Wiley DJ, Li Xiuhong, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. JAIDS. 2008;48(4):491–9. - PMC - PubMed
    1. Crum-Cianflone N, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS. 2009;23(1):41–50. - PMC - PubMed
    1. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Journal of National Cancer Institute. 2000;92(18):1500–10. - PubMed

Publication types

MeSH terms